Please use this identifier to cite or link to this item:
https://absmari.dspaces.org/jspui/handle/123456789/85Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Pattnaik, Aparna | - |
| dc.contributor.author | Pande, Nidhi | - |
| dc.date.accessioned | 2025-04-15T12:36:07Z | - |
| dc.date.available | 2025-04-15T12:36:07Z | - |
| dc.date.issued | 2022 | - |
| dc.identifier.issn | 2348-6805 | - |
| dc.identifier.uri | http://localhost:80/xmlui/handle/123456789/85 | - |
| dc.description.abstract | Dapsone is a well-known oral drug used for leprosy, dermatological conditions and a variety of infections. If taken overdose it can lead to many adverse drug reactions making it important to be recognised in the early stage. Here, we report a case of dapsone hypersensitivity syndrome that was managed by our team approach i.e. physicians, dermatologist, dietician, psychiatrist, physiotherapists, and many social and health professionals. This case is written to encourage the role of the physiotherapist in drug-induced weakness and how treatment plans can be designed for a successful outcome. | en_US |
| dc.language.iso | en | en_US |
| dc.publisher | Journal of Advanced Medical and Dental Sciences Research | en_US |
| dc.subject | Dapsone | en_US |
| dc.subject | hypersensitivity | en_US |
| dc.subject | drug-induced weakness | en_US |
| dc.subject | exercise | en_US |
| dc.subject | physiotherapy | en_US |
| dc.title | Exercise intervention in dapsone hypersensitivity syndrome | en_US |
| dc.type | Article | en_US |
| Appears in Collections: | 2022 | |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| Exercise intervention in dapsone hypersensitivity syndrome.pdf | 609.79 kB | Adobe PDF | View/Open |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.